Jennifer Herrmann

Dr. Jennifer Herrmann

Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Saarland, Germany
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2015 in Science
Verified
Journal Article
Closed access
PDF file
AKAngela Kling
Angela Kling
PLPeer Lukat
Peer Lukat
DADeepak V. Almeida
Deepak V. Almeida
ABArmin Bauer
Armin Bauer
EFEvelyne Fontaine
Evelyne Fontaine
RMRolf Müller
Rolf Müller
New for old—TB drug development: Tuberculosis (TB) is a global health threat for which there is only lengthy drug treatment. Patients need to consume multiple tablets over several months and frequently fail to complete their treatment. Consequently, drug-resistant strains of the pathogen have emerged, which add to the threat. Kling et al. revisited a natural product called griselimycin, extracted from the same organism that produced the prototype anti-TB drug, streptomycin. Unmodified griselimycin has poor pharmacological properties. However, one synthetic derivative had improved oral uptake and penetrated cells of the immune system that harbor the TB mycobacterium. In combination with other drugs, the griselimycin derivative showed high potency in mice with TB. Science , this issue p. 1106

15 December 2014 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
SBSascha Baumann
Sascha Baumann
JHJennifer Herrmann
Jennifer Herrmann
RRRitesh Raju
Ritesh Raju
HSHeinrich Steinmetz
Heinrich Steinmetz
KMKathrin I. Mohr
Kathrin I. Mohr
RMRolf Müller
Rolf Müller

10 July 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CRChristian A. Ruge
Christian A. Ruge
USUlrich F. Schaefer
Ulrich F. Schaefer
JHJennifer Herrmann
Jennifer Herrmann
JKJulian Kirch
Julian Kirch
OCOlga Cañadas
Olga Cañadas
CLClaus-Michael Lehr
Claus-Michael Lehr
The peripheral lungs are a potential entrance portal for nanoparticles into the human body due to their large surface area. The fact that nanoparticles can be deposited in the alveolar region of the lungs is of interest for pulmonary drug delivery strategies and is of equal importance for toxicological considerations. Therefore, a detailed understanding of nanoparticle interaction with the structures of this largest and most sensitive part of the lungs is important for both nanomedicine and nanotoxicology. Astonishingly, there is still little known about the bio-nano interactions that occur after nanoparticle deposition in the alveoli. In this study, we compared the effects of surfactant-associated protein A (SP-A) and D (SP-D) on the clearance of magnetite nanoparticles (mNP) with either more hydrophilic (starch) or hydrophobic (phosphatidylcholine) surface modification by an alveolar macrophage (AM) cell line (MH-S) using flow cytometry and confocal microscopy. Both proteins enhanced the AM uptake of mNP compared with pristine nanoparticles; for the hydrophilic ST-mNP, this effect was strongest with SP-D, whereas for the hydrophobic PL-mNP it was most pronounced with SP-A. Using gel electrophoretic and dynamic light scattering methods, we were able to demonstrate that the observed cellular effects were related to protein adsorption and to protein-mediated interference with the colloidal stability. Next, we investigated the influence of various surfactant lipids on nanoparticle uptake by AM because lipids are the major surfactant component. Synthetic surfactant lipid and isolated native surfactant preparations significantly modulated the effects exerted by SP-A and SP-D, respectively, resulting in comparable levels of macrophage interaction for both hydrophilic and hydrophobic nanoparticles. Our findings suggest that because of the interplay of both surfactant lipids and proteins, the AM clearance of nanoparticles is essentially the same, regardless of different intrinsic surface properties.

6 June 2013 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
XBXiaoying Bian
Xiaoying Bian
JFJun Fu
Jun Fu
APAlberto Plaza
Alberto Plaza
JHJennifer Herrmann
Jennifer Herrmann
DPDominik Pistorius
Dominik Pistorius
RMRolf Müller
Rolf Müller

20 April 2016 in Scientific Reports
Verified
Journal Article
Open access
QTQiang Tu
Qiang Tu
JYJia Yin
Jia Yin
JFJun Fu
Jun Fu
JHJennifer Herrmann
Jennifer Herrmann
YLYue-zhong Li
Yue-zhong Li
YZYouming Zhang
Youming Zhang
Bacterial competent cells are essential for cloning, construction of DNA libraries, and mutagenesis in every molecular biology laboratory. Among various transformation methods, electroporation is found to own the best transformation efficiency. Previous electroporation methods are based on washing and electroporating the bacterial cells in ice-cold condition that make them fragile and prone to death. Here we present simple temperature shift based methods that improve DNA transformation and recombineering efficiency inE. coliand several other gram-negative bacteria thereby economizing time and cost. Increased transformation efficiency of large DNA molecules is a significant advantage that might facilitate the cloning of large fragments from genomic DNA preparations and metagenomics samples.

1 November 2018 in Cell Reports
Verified
Journal Article
Open access
DCDhruv Chauhan
Dhruv Chauhan
EBEva Bartok
Eva Bartok
MGMoritz M. Gaidt
Moritz M. Gaidt
FBFlorian J. Bock
Florian J. Bock
JHJennifer Herrmann
Jennifer Herrmann
VHVeit Hornung
Veit Hornung
IL-1β is a cytokine of pivotal importance to the orchestration of inflammatory responses. Synthesized as an inactive pro-cytokine, IL-1β requires proteolytic maturation to gain biological activity. Here, we identify intrinsic apoptosis as a non-canonical trigger of IL-1β maturation. Guided by the discovery of the immunomodulatory activity of vioprolides, cyclic peptides isolated from myxobacteria, we observe IL-1β maturation independent of canonical inflammasome pathways, yet dependent on intrinsic apoptosis. Mechanistically, vioprolides inhibit MCL-1 and BCL2, which in turn triggers BAX/BAK-dependent mitochondrial outer membrane permeabilization (MOMP). Induction of MOMP results in the release of pro-apoptotic factors initiating intrinsic apoptosis, as well as the depletion of IAPs (inhibitors of apoptosis proteins). IAP depletion, in turn, operates upstream of ripoptosome complex formation, subsequently resulting in caspase-8-dependent IL-1β maturation. These results establish the ripoptosome/caspase-8 complex as a pro-inflammatory checkpoint that senses the perturbation of mitochondrial integrity.